Skip to main content
. Author manuscript; available in PMC: 2023 Apr 18.
Published in final edited form as: ACS Appl Bio Mater. 2022 Mar 27;5(4):1519–1527. doi: 10.1021/acsabm.1c01272

Table 1.

Hemolytic Activities of Clinically Used Lock Solutions and NOreLSa

Lock Solution 0.06% LS 0.09% LS 0.2% LS
VAN (5 mg/mL) 0.0 0.0 0.0
GEN (5 mg/mL) 0.0 0.0 0.001 ± 0.023
HEP (10k unit/mL) 0.005 ± 0.023 0.0 0.0
NOreLS (1 mg/mL) 0.005 ± 0.023 0.0 0.0
NOreLS (5 mg/mL) 0.0 0.0 0.0
NOreLS (10 mg/mL) 0.0 0.0 0.0
NOreLS (20 mg/mL) 0.0 0.0 0.0
a

Data are shown as the mean ± standard deviation (n = 3 repeats tested per formulation).